CONFERENCES

      Congress of Pharmacy with International Participation

      This conference focuses on the latest developments in the field of pharmacy, with topics ranging from drug development to patient care. The conference is aimed at pharmacists, researchers, industry professionals, and stakeholders involved in the study and application of pharmacy. It provides a forum for sharing knowledge and collaborating on new approaches to pharmacy practice and education. The conference aims to promote the exchange of ideas and experiences between different areas of pharmacy and to foster collaborations between researchers, practitioners, and industry leaders. It also offers a platform for the presentation of cutting-edge research and innovative developments in pharmacy, with a focus on improving patient outcomes and advancing the field of pharmacy.

      8th Congress of Pharmacy with International Participation 2023

      Date

      Apr 27, 2023 - Apr 30, 2023

      Location

      Borovets, Bulgaria

      Organized by the Bulgarian Pharmaceutical Society, this Congress brings together over 500 participants and has for theme this year "Escape from the Pandemonium:Pharmaceutical Restart 2023".  

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.